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Crouzon syndrome and Pfeiffer syndrome are both autosomal dominant craniosynostotic disorders that can be
caused by mutations in the fibroblast growth factor receptor 2 (FGFR2) gene. To determine the parental origin of
these FGFR2 mutations, the amplification refractory mutation system (ARMS) was used. ARMS PCR primers were
developed to recognize polymorphisms that could distinguish maternal and paternal alleles. A total of 4,374 bases
between introns IIIa and 11 of the FGFR2 gene were sequenced and were assayed by heteroduplex analysis, to
identify polymorphisms. Two polymorphisms (1333TA/TATA and 2710 C/T) were found and were used with two
previously described polymorphisms, to screen a total of 41 families. Twenty-two of these families were shown to
be informative (11 for Crouzon syndrome and 11 for Pfeiffer syndrome). Eleven different mutations in the 22
families were detected by either restriction digest or allele-specific oligonucleotide hybridization of ARMS PCR
products. We molecularly proved the origin of these different mutations to be paternal for all informative cases
analyzed ( ; 95% confidence limits 87%–100%). Advanced paternal age was noted for the fathers57P = 2.4# 10
of patients with Crouzon syndrome or Pfeiffer syndrome, compared with the fathers of control individuals
( years vs. years, ). Our data on advanced paternal age corroborates and extends34.50 7.65 30.45 1.28 P ! .01
previous clinical evidence based on statistical analyses as well as additional reports of advanced paternal age
associated with paternal origin of three sporadic mutations causing Apert syndrome (FGFR2) and achondroplasia
(FGFR3). Our results suggest that older men either have accumulated or are more susceptible to a variety of germline
mutations.
Introduction
Crouzon syndrome (MIM 123500) and Pfeiffer syn-
drome (MIM 101600) are autosomal dominantly in-
herited craniosynostosis conditions that are both genet-
ically heterogeneous (Passos-Bueno et al. 1999). The
majority of patients with Crouzon syndrome or Pfeiffer
syndrome have mutations in the extracellular immu-
noglobulin III domain of the fibroblast growth-factor
receptor 2 (FGFR2) gene. Crouzon syndrome affects cra-
nial development and is characterized by craniosynos-
tosis, exophthalmos, and midface hypoplasia. The birth
prevalence of Crouzon syndrome is estimated to be
15–16/1 million births (Cohen and Kreiborg 1992), and
it is also estimated that ∼30%–60%of cases are sporadic
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(al-Qattan and Phillips 1997). Pfeiffer syndrome in-
volves craniofacial abnormalities as well as abnormali-
ties of the hands and feet. Clinical phenotypes in Pfeiffer
syndrome span a wide spectrum. The more severe types
of Pfeiffer syndrome are due to de novo mutations only,
whereas the less-severe types are due to inherited mu-
tations as well as to de novo mutations (Cohen 1993;
Jones 1997). The birth prevalence of Pfeiffer syndrome
is assumed to be less than that of Crouzon syndrome.
Sporadic cases of Crouzon syndrome and Pfeiffer syn-
drome—as well as those of other dominant skeletal dys-
plasias, such as achondroplasia and Apert syndrome—
have previously been associated with advanced paternal
age (Jones et al. 1975). Such sporadic cases of achon-
droplasia and Apert syndrome have been shown to be
caused exclusively by mutations arising in the paternal
germline (Moloney et al. 1996; Wilkin et al. 1998).
Unlike both Apert syndrome and achondroplasia, in
which mutational heterogeneity is exceedingly limited,
at least 32 different mutations have been found in pa-
tients with Crouzon syndrome and at least 26mutations
have been found in patients with Pfeiffer syndrome (Pas-
sos-Bueno et al. 1999). In the present study, we show
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Table 1
FGFR2 Oligonucleotides
OLIGONUCLEOTIDES
SEQUENCE
(5′r3′)
POSITIONa AT
DESCRIPTION5′ End 3′ End
1 CCCTTTAATGCCGCTGTTTAG 532 552 Intron IIIb amplification
2 AACCCAGAGAGAAAGAACAGTA 2194 2173 Intron IIIb amplification
3 ATCATTCCTGTGTCGTCTAGC 1974 1994 Intron IIIc amplification
4 TCCGCAGGGGGATACGTTTG 4358 4338 Intron IIIc amplification
5 TCCATGCCTGTTTAATACG 1134 1152 1333TA/TATA polymorphism
amplification
6 GACACCTCACCCATCCTC 1582 1565 1333TA/TATA polymorphism
amplification
7 CGTCCAGTAGTACATTCAT 1340 1322 TA ASO
8 CGTCCAGTATAGTACATTCAT 1342 1322 TATA ASO
9 TGCTTTCATCCCACTTTG 2551 2568 2710C/T polymorphism
amplification
10 AGCAAACCACAGTCTCTG 2940 2923 2710C/T polymorphism
amplification
11 TAGAATGGACTTTTGGTT 2697 2714 T ASO
12 TAGAATGGACTTTCGGTT 2697 2714 C ASO
13 AAAAAACCCAGAGAGAAAGAACAGTATA 2198 2171 ARMS amplification
14 GAGCTCATCTTAATGAATGTACTACT 1310 1335 TA ARMS primer
15 GAGCTCATCTTAATGAATGTACTATA 1310 1335 TATA ARMS primer
a Numbered according to GenBank (accession number AF169399).
Figure 1 Partial map of the human FGFR2 gene. Unblackened arrow indicates the ARMS primer; diagonally hatched arrows, ASOs;
blackened arrows, all other primers; vertical arrows, locations of the polymorphisms flanking exons IIIa and IIIc.
that 11 different mutations that are responsible for spo-
radic cases of either Crouzon syndrome or Pfeiffer syn-
drome also arise in the paternal germline. Furthermore,
we confirm advanced paternal age in the fathers of af-
fected individuals.
Subjects and Methods
Subjects
A total of 41 families consisting of one or both un-
affected parents and their affected child were studied.
This sample consisted of 18 American families, 18 Brit-
ish families, 1 Israeli family, 1 French family, 1 Irish
family, 1 Norwegian family, and 1 Polish family. In-
formed consent for phenotypic information collection
and genetic analysis was obtained from the patient and/
or the parent(s), after approval was given by the appro-
priate institutional review board. Blood for DNA iso-
lation and analysis was obtained from the patient and
parent(s). Of the 41 families, 22 were found to be in-
formative (11 for Crouzon syndrome and 11 for Pfeiffer
syndrome), where the proband was heterozygous for at
least one polymorphism and at least one parent was
homozygous for a given polymorphism. Of the 22 in-
formative families and the 19 noninformative families,
blood was obtained from both the parents and the pa-
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Figure 2 Polymorphism detection in three unrelated control in-
dividuals. A, 1333TA/TATA polymorphism. Top panels show gel elec-
trophoresis of ARMS PCR products derived from primers 13 and 14
(top left) or from primers 13 and 15 (top right). Bottom panels show
PCR products that were amplified with primers 5 and 6, were dotted
onto filters, and were hybridized with either ASO 7 (bottom left) or
ASO 8 (bottom right). Lane 1 represents the heterozygous individual;
lane 2, the individual that is homozygous for the TATA polymorphism;
lane 3, the individual that is homozygous for the TA polymorphism.
B, 2710C/T polymorphism. Top panels show gel electrophoresis of
PCR products amplified with the use of primers 9 and 10. Bottom
panels show the same PCR products dotted onto filters and hybridized
with either ASO 12 (bottom left) or ASO 11 (bottom right). No ARMS
PCR products are shown. Lane 1 represents the heterozygous indi-
vidual; lane 2, the individual that is homozygous for the T poly-
morphism; lane 3, the individual that is homozygous for the C
polymorphism.
tient in 20 and 17 families, respectively. In the remaining
two families in each category, blood was available from
only the mother and the patient. In these four cases, the
father was clinically unaffected. Parental ages were ob-
tained for all of the mothers and for 39/41 fathers, at
the time of their child’s birth. The ages of the parents
of affected children were compared with the ages of the
parents in a control group, for all of the British mothers
and for 16/18 British fathers (Office of Population Cen-
suses and Surveys 1960, 1974–97) and for 14/18 Amer-
ican mothers and fathers, where matched parental age
data could be calculated from raw data available for the
year of the child’s birth (U.S. Department of Health and
Human Services 1967, pp. I-12, I-122; 1974, pp. I-14,
I-56; 1988a, pp. 14, 95; 1988b, pp. 14, 95; 1989, pp.
15, 99; 1990, pp. 15, 99; 1993, pp. 104, 109; 1994, pp.
108, 113; 1995a, pp. 108, 113; 1995b, pp. 108, 113;
1999, pp. 108, 113; Riccardi 1988).
Paternal Identity and Sex Identification
Informative families for which there was DNA from
the father were checked for paternity by analysis of ei-
ther three polymorphic markers (D18S51, D19S253,
and D21S11) (Urquart et al. 1995) or HLA class I mark-
ers. Typing for HLA class I (A, B, and C) allele groups
comparable to serologically defined antigens was per-
formed by use of the microsequence-specific primer (SSP)
method. The tests were performed by use of the Pel-
Freez SSP Unitray, according to the manufacturer’s in-
structions. Ethnic background, when known, was
matched to the corresponding allele frequencies. In cases
where ethnic background was not available, the allele
frequencies for white, African Caribbean, and Asian
(from the Indian subcontinent) individuals (Urquart et
al. 1995) were used to calculate the likelihood that the
alleged father is the biological father. Statistical analysis
based on Bayes theorem provided a 95% probability
that we had studied the biological fathers (Zachary et
al. 1997). In the two informative case patients for which
no blood samples were available from the fathers, the
maternal contribution was homozygous for the allele
that did not contain the mutation; thus, the paternal
determination was made by exclusion.
Confirmation of the sex of maternal and paternal sam-
ples was made with the use of X-Y homologous primers
(AMXY-1F and AMXY-2R) flanking the amelogenin
gene on the X chromosome and the amelogenin-like se-
quence on the Y chromosome (Nakahori et al. 1991).
The X-specific sequence has an additional 177-bp insert,
which makes the size difference between the X and Y
PCR products distinctive on gel electrophoresis.
Identification of Polymorphic Variants
The upstream intron (intron IIIb) of exon IIIc (also
referred to as “exon 10” or “exon B”) was PCR am-
plified by use of primers 1 and 2 (annealing at 54C for
1 min and extension at 72C for 4 min per cycle [35
cycles]) (table 1; fig. 1). The 1,663-bp PCR product was
cloned by use of the TA Cloning Kit (Invitrogen). Plas-
mid DNA was isolated by use of the Qiagen Plasmid
Midi-Kit. Clones were sequenced by the Johns Hopkins
Genetic Research Core Facility, by means of both a 373A
automated DNA sequencer (Applied Biosystems) and the
fluorescent dideoxy terminator method (Smith et al.
1986), with use of these primers and other primers gen-
erated from the sequence. The downstream intron (in-
tron IIIc) of exon IIIc was PCR amplified with the use
of primers 3 and 4 (annealing at 50C for 1 min and
extension at 72C for 4 min). The resulting 2,385-bp
PCR product was cloned andwas sequenced as described
above. For confirmation, plasmid artificial chromosome
(PAC) 304H11 and 71B17 clones located in this region
were sequenced in the opposite direction. Both PAC
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Table 2
Informative Patients, Their Diagnoses and Mutations, and the Methods Used to Detect the Mutations
PATIENT ID
Number DIAGNOSISa
AGE OF
FATHERb
(years)
AGE OF
MOTHERb
(years) EXON MUTATION
TYPE OF
MUTATION
METHOD USED
TO DETECT
MUTATIONc REFERENCE
C 6 CZ 35 35 IIIa S267P (TrC) Missense BslI Oldridge et al. (1995)
C 4 CZ 60 31 IIIa C278F (GrT) Missense BbsI Oldridge et al. (1995)
C 11 CZ 44 33 IIIa Q289P (ArC) Missense BsaJI Oldridge et al. (1995)
FCAB 1452 CZ 41 35 IIIc C342S (GrC) Missense BsaAI or StyI Present study
1580 CZ NAd 22 IIIc C342Y (GrA) Missense RsaI Present study
C 12 CZ 28 28 IIIc C342Y (GrA) Missense RsaI Oldridge et al. (1995)
FCJO OM12 CZ 35 28 IIIc C342Y (GrA) Missense RsaI Present study
1836 CZ 33 31 IIIc C342W (CrG) Missense ASO Present study
FCKR OM6 CZ 34 38 IIIc A344A (GrA) Splice AciI Li et al. (1995)
FCCD 1946 CZ 31 27 IIIc A344A (GrA) Splice AciI Present study
1839 CZ 39 36 IIIc S347C (CrG) Missense ASO Present study
1583 P 35 34 IIIa C278F (GrT) Missense BbsI Present study
FPPB 28 P 39 32 IIIa C278F (GrT) Missense BbsI Meyers et al. (1996)
FPKH 1552 P 26 27 IIIa C278F (GrT) Missense BbsI Present study
FPAM 57 P 25 23 IIIa W290C (GrC) Missense AlwI Przylepa et al. (1998)
1647 P 33 32 IIIc C342S (GrC) Missense StyI Present study
1963 (case 2) P 33 36 IIIc C342R (TrC) Missense CfoI Rutland et al. (1995)
1956 (case 4) P 38 28 IIIc C342R (TrC) Missense CfoI Rutland et al. (1995)
FPRW 39 P 38 39 IIIc C342R (TrC) Missense CfoI Meyers et al. (1996)
FPEW OM32 P 32 27 IIIc C342R (TrC) Missense CfoI Meyers et al. (1996)
FPRA OM20 P 22 22 IIIc C342Y (GrA) Missense RsaI Present study
1833 (patient 4) P 30 32 IIIc 940-2ArT Splice EaeI Oldridge et al. (1999)
a CZ = Crouzon syndrome; P = Pfeiffer syndrome.
b Age of parent at time of patient’s birth.
c  = mutation created a restriction site;  = mutation destroyed a restriction site.
d NA = not available.
clones were obtained by screening of a human PAC li-
brary (PAC-6541; Genome Systems) with a probe that
was generated by PCR amplifying across FGFR2 exon
4 with intronic primers 5′-ACTTTGCTATGGAGA-
AGG-3′ and 5′-AAGAAGACAGGTGACAGG-3′. Se-
quence information was deposited in GenBank (acces-
sion number AF169399).
To search for polymorphic variants in the sequence,
PCR products of 202–310 bp were amplified with the
use of several overlapping primer sets generated from
the sequence of the two flanking introns (IIIb and IIIc)
and the genomic DNA from 20 control individuals. Het-
eroduplex analysis was done on 5 ml of the PCR product,
by use of mutation-detection-enhancement (MDE; FMC
Corporation) gel electrophoresis, according to the man-
ufacturer’s protocol. PCR products with variations in
mobility were cloned and were sequenced.
We found one polymorphism in intron IIIb and an-
other polymorphism in intron IIIc. Intron IIIb, which
has a TA/TATA polymorphism at nucleotide position
1333 (nucleotide numbers are derived from GenBank
[accession number AF169399]), was PCR amplified for
allele-specific oligonucleotide (ASO) hybridization or for
amplification refractory mutation system (ARMS) anal-
ysis (see below). For detection by use of ASO, part of
intron IIIb was PCR amplified with primers 5 and 6
(58C annealing, 449-bp product; see table 1 and fig.
1). A total of 10–20 ml product was added to 80 ml 0.4
M NaOH and 25 mM Na2 EDTA solution, and samples
were dotted onto a Zetabind filter. ASOs (ASO 7 and
ASO 8) were developed for each of the polymorphic
alleles. After hybridization, the filter was washed at 52C
(for ASO 7) or 54C (for ASO 8), was autoradiographed,
and was developed for analysis (fig. 2).
Intron IIIc, which contains a C/T polymorphism at
nucleotide position 2710, was amplified with the use of
primers 9 and 10 (54C annealing, 390-bp product).
After ASO hybridization, the filter was washed at 52C
(for ASO 11) or 53C (for ASO 12), was autoradiogra-
phed, and was developed for analysis (fig. 2). To deter-
mine the frequency of these polymorphisms, genomic
DNA from at least 50 unrelated CEPH control individ-
uals was amplified with the use of either ARMS primers
(see data below) or primers 5 and 6, for ASO-hybridi-
zation analysis for the 1333TA/TATA polymorphism,
and with the use of primers 9 and 10, for ASO-hybrid-
ization analysis for the 2710C/T polymorphism.
Design of ARMS Analysis
Mutations in our patients with Crouzon syndrome or
Pfeiffer syndrome lie either in the 191-bp exon IIIa (also
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Table 3
Parental Ages in Families with Crouzon Syndrome and Pfeiffer Syndrome
FAMILIES
NO. OF
INDIVIDUALS
MEAN  SD AGE (RANGE)
(years)
NO. OF
INDIVIDUALS
MEAN  SD AGE (RANGE)
(years)
DAGE
(years)
Fathers Mothers
Informative:
Crouzon syndrome 10 38.00  9.06 (28–60) 11 31.18  4.67 (22–38) 6.82
Pfeiffer syndrome 11 31.91  5.66 (22–39) 11 30.18  5.29 (22–39) 1.73
Total 21 34.81  7.92a (22–60) 22 30.68  4.89b (22–39) 4.13c
Noninformative:
Crouzon syndrome 12 31.00  4.69 (25–40) 13 28.54  4.03 (24–35) 2.46
Pfeiffer syndrome 6 36.83  7.36 (28–48) 6 27.83  5.23 (22–35) 9.00
Total 18 32.94  6.18 (25–48) 19 28.32  4.31 (22–35) 4.63c
Informative and Noninformative:
Crouzon syndrome 22 34.18  7.71 (25–60) 24 29.75  4.45 (22–38) 4.43
Pfeiffer syndrome 17 33.65  6.55 (22–48) 17 29.35  5.23 (22–39) 4.30
Total 39 33.95  7.14 (22–60) 41 29.59  4.73 (22–39) 4.39d
Informative:
Matched affected 17e 35.35  8.46 (22–60) 18f 30.44  4.82 (22–38) 4.91c
Matched control 17e 30.66  1.57 (27.39–32.95) 18f 27.47  1.81 (24.10–30.30)
Difference 4.69g 2.97h
Informative and Noninformative:
Matched affected 30i 34.50  7.65 (22–60) 32j 29.88  4.66 (22–38) 4.62d
Matched control 30i 30.45  1.28 (27.39–32.95) 32j 27.18  1.53 (24.10–30.30)
Difference 4.05h 2.70h
a (compared with average paternal age for all noninformative families).P = .42
b (compared with average maternal age for all noninformative families).P = .11
c by the t-test..01 ! P ! .05
d by the t-test.P ! .01
e Eleven British and 6 American fathers, for whom matched control data for paternal ages at the year of the affected child’s birth were
available, were used in this calculation. This subset of families included families informative for either Crouzon syndrome or Pfeiffer syndrome.
f Twelve British and 6 American mothers, for whom matched control data for maternal ages at the year of the affected child’s birth were
available, were used in this calculation. This subset of families included families informative for either Crouzon syndrome or Pfeiffer syndrome.
g by the one-tailed paired t-test.P = .022
h by the one-tailed paired t-test.P ! .01
i Sixteen British and 14 American fathers, for whom matched control data for paternal ages at the year of the affected child’s birth were
available, were used in this calculation. This subset of families included families that are either informative or noninformative for Crouzon
syndrome or Pfeiffer syndrome.
j Eighteen British and 14 American mothers, in whom matched control data for maternal ages at the year of the affected child’s birth were
available, were used in this calculation. This subset of families included families that are either informative or noninformative for Crouzon
syndrome and Pfeiffer syndrome.
referred to as “exon 8” or “exon U”), in the 145-bp
exon IIIc, or in the splice-acceptor site for exon IIIc of
the FGFR2 gene (fig. 1). For patients with mutations in
exon IIIa, we used the ARMS developed by Moloney et
al. (1996), to amplify individual alleles by use of primers
specific for single-nucleotide polymorphisms, a G/A var-
iant in the upstream intron, and a C/A variant in the
downstream intron. On the basis of the identification of
a polymorphism upstream of exon IIIc, we developed
ARMS primers with which to distinguish the TA and
TATA variants. A segment of genomic DNA was am-
plified by use of either primers 13 and 14 (annealing at
64C) or primers 13 and 15 (annealing at 63C; see table
1 and fig. 1). PCR amplification yielded products of 889
bp and 891 bp, respectively. For each affected child and
the parent(s), both PCR reactions were done to assess
whether the family was informative. If the family was
informative, we proceeded to analyze for a specific mu-
tation by means of either a previously published restric-
tion digest or ASO-hybridization detection. Specific mu-
tations, types of mutations, and methods of mutation
detection are summarized in table 2. By using the poly-
morphism data, we ascertained the phase of the muta-
tion, and therefore the origin of the mutation was
known.
Results
Parental Ages
The mean paternal and maternal ages were deter-
mined for the families in the present study (table 3). The
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Figure 3 Determination of the origin of mutation by means of ARMS PCR followed by restriction digest. A, top panel, primers 13 and
14 were used to amplify 889 bp, starting from the TA variant and extending 3′ to exon IIIc (in which the mutation is located). Unmarked lane
indicates size markers fX174 DNA digested with HaeIII. Templates for ARMS PCR are as follows: affected child (subject 1580) (lane C),
unaffected father (subject 1587) (lane F), and unaffected mother (subject 1586) (lane M). A, bottom panel, primers 13 and 15 were used to
amplify 891 bp from the TATA variant to 3′ of the exon IIIc. Templates for ARMS PCR are the same as those for the top panel. B, The GrA
nucleotide change for the C342Y mutation creates an RsaI restriction site in the patient. Top panel indicates digest of ARMS PCR products
amplified with the use of primers 13 and 14. Bottom panel indicates digest of ARMS PCR products amplified with the use of primers 13 and
15. Samples are as follows: affected child, undigested (left lane C); affected child, digested (right lane C); unaffected father, digested (lane F);
and unaffected mother, digested (laneM). The arrow indicates the smaller digested product from the child’s allele containing theTApolymorphism.
mean parental ages for all of the families in both the
informative (mean paternal age years;34.81 7.92
mean maternal age years) and noninfor-30.68 4.89
mative (mean paternal age years; mean32.94 6.18
maternal age years) groups are similar.28.32 4.31
Statistical analysis with use of the t-test was not able to
reject the null hypothesis that the mean parental ages in
each group were the same, thus arguing against an age
bias in families that are informative. The apparent dif-
ference between the mean paternal ages of the fathers
of the families that are informative (for Crouzon syn-
drome years; for Pfeiffer syndrome38.00 9.06
years) versus the fathers of the families31.91 5.66
that are noninformative (for Crouzon syndrome
years; for Pfeiffer syndrome31.00 4.69 36.83
years) is most likely a result of the small sample7.36
sizes—in particular, the six families that are noninfor-
mative for Pfeiffer syndrome. Since, in this study, Crou-
zon syndrome and Pfeiffer syndrome are both the result
of FGFR2 mutations and since identical FGFR2 muta-
tions can be found in either syndrome, patients can be
viewed on a phenotypic continuum where patients with
Crouzon syndrome have a craniosynostotic phenotype
and where patients with Pfeiffer syndrome have this phe-
notype as well as abnormalities of the digits. With this
in mind and given the fact that there is no significant
difference between the mean parental ages of the infor-
mative and noninformative groups, we chose to combine
these parental ages and to compare our data against the
average parental ages in the general population to look
for evidence of a parental age effect.
An exact analysis of a parental age effect can be done
by comparing the ages of parents of affected children
with the ages of a control population for which parental
age data also exist, specific for the exact year of the
affected child’s birth (referred to here as “matched
data”). Because there was no statistical difference be-
tween the parental ages in the informative versus the
noninformative groups, we were able to use those in-
formative and noninformative families for which
matched data were available. This was possible for all
of the British mothers, for 16/18 British fathers, and for
14/18 American families. The difference between the pa-
ternal age at the time of the child’s birth and the mean
paternal age in the general population for that year of
birth was calculated. For the British families, paternal
age data differed, depending on whether the child was
born in or out of wedlock; this variable was taken into
consideration when the calculations were made. Simi-
larly, the difference between the maternal age at the time
of the child’s birth and the mean maternal age in the
general population for that year was also calculated.
Significant increases in both paternal age (4.05 years,
) and maternal age (2.70 years, ) wereP ! .01 P ! .01
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Table 4
Comparison of Two Parental Age Studies
STUDY AND SYNDROME
NO. OF
INDIVIDUALS
MEAN  SD AGE
(years)
NO. OF
INDIVIDUALS
MEAN  SD AGE
(years)
DAGE
(years)
Fathers Mothers
Present study:
Crouzon syndromea 22 34.18  7.71 24 29.75  4.45 4.43
Pfeiffer syndromea 17 33.65  6.55 17 29.35  5.23 4.30
Jones et al. (1975):
Crouzon syndrome 38 33.90  8.30 38 28.60  5.90 5.30
Pfeiffer syndrome 10 29.20  4.00 10 27.00  5.30 2.20
a Informative and noninformative families.
Figure 4 Determination of the origin of mutation by means of ARMS PCR followed by ASO hybridization. A, ARMS PCR products
spanning the region containing the TA/TATA polymorphism and exon IIIc, which contains the mutation. Templates for PCR: affected child
(subject 1839) (lane C), unaffected father (subject 1841) (lane F), and unaffected mother (subject 1840) (lane M). Top lanes were PCR amplified
with the use of primers 13 and 15, which recognize the TATA polymorphism. Bottom lanes were PCR amplified with the use of primers 13
and 14, which recognize the TA polymorphism. B, diagram of the filter dotted with ARMS PCR products in the same orientation that is seen
in A. C, Left filter is hybridized with ASO (GGGTAATTCTATTGGGAT), which recognizes the normal allele. Right filter is hybridized with
ASO (GGGTAATTGTATTGGGAT), which recognizes the CrG nucleotide change in the S347C mutation in exon IIIc.
noted, thus suggesting an advanced parental age effect
on sporadic mutations causing both Crouzon syndrome
and Pfeiffer syndrome. A significant increase in paternal
age (4.69 years, ) was noted for the casesP = .022
proved molecularly to be paternal in origin (informative
cases). Of most significance, the differences between
mean paternal age and mean maternal age (referred to
as “Dage” in table 3) were observed when data were
generated from the informative, noninformative, or
combined groups, irrespective of whether these groups
were matched for the year of the child’s birth. Taken
together, these results are consistent in demonstrating an
increased paternal age in sporadic cases of Crouzon syn-
drome and Pfeiffer syndrome.
Polymorphism Frequency
The frequency of the TA variant of the 1333TA/TATA
polymorphism in intron IIIb was determined to be
68.75%, whereas the frequency of the other variant,
TATA, was found to be 31.25% ( ). The fre-n = 112
quency of the C polymorphism in intron IIIc was de-
termined to be 73.94%, whereas the other variant, T,
was only found in 26.06%of the alleles ( ). Figuren = 142
2 depicts the identification of these polymorphic variants
in unrelated control individuals by means of the two
previously described methods (ARMS and ASO).
Thirty-eight control individuals were screened for
both polymorphisms. In this subsample, the TATA var-
iant was only present when the T variant was present
as well. We analyzed the haplotypes present in the 15
informative patients with mutations in exon IIIc, to de-
termine whether a certain haplotype was predisposed to
the mutation. In 11/15 patients, the mutation occurred
on the TATA-T background, and, in the remaining four
cases, the mutation occurred in the TA-C background
( ). With this sample size there is no clear pre-P = .042
disposition to mutations occurring on one particular
haplotype.
Identification of Origin of Mutation
The parental origin of mutations in sporadic cases of
Crouzon and Pfeiffer syndromes was determined by the
use of ARMS allele-specific PCR followed by either re-
striction digest or ASO hybridization specific for mu-
tations. For 22 informative cases, all were of paternal
origin for 11 different mutations. For example, figure 3
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shows an informative family in which the C342Y mu-
tation in exon IIIc of the affected patient (patient 1580)
was detected by restriction-enzyme digestion. ARMS
PCR amplification of the TA polymorphism (with the
use of primers 13 and 14) resulted in a product for the
affected child and both parents. ARMS PCR amplifi-
cation of the TATA polymorphism (with the use of prim-
ers 13 and 15) yielded a product from only the affected
child and the normal father. Therefore, both the child
and the father are heterozygous, whereas the mother is
homozygous for the TA polymorphism. Digestion of the
child’s allele with the TATA polymorphism, the allele
inherited from the father, with the use of RsaI results in
a smaller DNA fragment, since the mutation created a
new restriction site. The father’s TATA allele did not
digest. Digestion of the other allele with the TA poly-
morphism from the child and the father, as well as di-
gestion of both of the mother’s alleles, with RsaI, did
not result in smaller DNA fragments, because these al-
leles do not contain the mutation. Therefore, the origin
of the mutation is determined to be paternal.
Figure 4 shows another informative family in which
the S347C mutation in exon IIIc of the affected child
was detected by use of ASO hybridization. As in the
previous case, ARMS primers were used to amplify in-
dividual alleles, each of which contained one of the poly-
morphic variants. In this family, the affected child and
the normal mother are heterozygous, whereas the father
is homozygous for the TA polymorphism. ASOs 5′-
GGGTAATTCTATTGGGAT-3′ and 5′-GGGTAATTG-
TATTGGGAT-3′ were used to hybridize to the normal
and mutant alleles, respectively. The former ASO hy-
bridized to the normal allele in the affected child as well
as to both alleles in both unaffected parents. The latter
ASO, which recognized the mutation, hybridized only
to the child’s allele containing the TA polymorphism that
was inherited from the father. The origin of the mutation
is again determined to be paternal.
For those patients that had mutations in exon IIIa, we
used ARMS primers developed by Moloney et al. (1996)
to recognize polymorphisms flanking exon IIIa. Detec-
tion of those mutations required restriction digests.
Discussion
We have molecularly proved a paternal origin of mu-
tation in all 22 informative cases of sporadic Crouzon
syndrome and Pfeiffer syndrome. Furthermore, in our
analysis of parental age, we have shown that there is an
advanced parental age effect for these syndromes. These
data provide strong evidence that the parental age effect
is primarily paternal. Although the association between
older paternal age and sporadic mutations—hypo-
thesized to be paternal in origin—has been noted since
the beginning of this century, Jones et al. described the
first association of older paternal age with Crouzon syn-
drome and Pfeiffer syndrome in 1975. A comparison of
the original data from 1975 with data from the present
study is shown in table 4. Both sets of data are similar,
with the added observation that we have now molecu-
larly proved the origin of mutation to be paternal.
More than 10 genetic disorders are associated with
advanced paternal age; half of them (Apert syndrome,
achondroplasia, multiple endocrine neoplasia type 2B
[Carlson et al. 1994], Crouzon syndrome, and Pfeiffer
syndrome) have definitively been shown to be the result
of mutations that are paternal in origin. The long ob-
served paternal-age effect was explained by Penrose
(1955) in his “copy error hypothesis,” which was based
on the different mechanisms of gametogenesis in males
and females. In males, 36 divisions give rise to the sper-
matogonia that are present before puberty begins. From
puberty onward, the spermatogonia stem cells divide
every 16 days, which is equivalent to 23 divisions per
year. Thus, in a 30-year-old male, for example, 430
divisions of the stem cells have occurred (Heller and
Clermont 1963; Vogel and Rathenberg 1975; Crow
1997). If one compares the processes of spermatogeneis
and oogenesis, a major difference is immediately ap-
parent: ∼24 divisions occur in the female, to produce
all of the oocytes already present at birth (Chandley
1991).
Examination of the processes of gametogenesis allows
one to hypothesize about the types of mutations one
would see in older men versus older women. Thus, in
men, it is easy to see that, given a fixed error-of-repli-
cation rate, the more divisions that occur (i.e., the older
the male), the more mutations that occur (i.e., the more
children born with a specific disorder), for a supposedly
linear rate of mutation that is dependent on the age of
the male (i.e., the number of divisions). These mutations
would most likely be point mutations (Vogel and Rath-
enberg 1975; Chandley 1991; Crow 1997). During ex-
amination of the data for the frequency of sporadic cases
of achondroplasia, Apert syndrome, Crouzon syn-
drome, or Pfeiffer syndrome versus paternal age, a linear
relationship is not evident. In fact, the curve steepens
as the rate of increase in the mutation rate itself in-
creases with age (Vogel and Rathenberg 1975; Risch et
al. 1987; Crow 1997). One explanation for this could
be that the efficiency of the proofreading of the repli-
cation machinery in spermatogenesis declines with age
(Crow 1997). This suggests that there are other as-yet-
unknown mechanisms that contribute to this advanced
paternal-age effect.
It is interesting to note that, in our study, 11 different
point mutations occurred in the informative families
and that, for every one of these mutations, the origin
of mutation was paternal. Furthermore, nine of these
mutations were missense, and the other two were splice-
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site mutations. In the two previous reports of paternal
origin of mutation for Apert syndrome and achondro-
plasia (Moloney et al. 1996; Wilkin et al. 1998), two
point mutations caused each disorder. These mutations
were all missense mutations, and two of the four mu-
tations occurred within a CpG dinucleotide and account
for 197% of all reported cases. The germline frequen-
cies of these mutations were and65.0# 10 2.7#
for the Apert mutations (Moloney et al. 1996) and610
5.5– for the achondroplasiamutations (Bellus628# 10
et al. 1995). Spontaneous deamination of a methylated
cytosine could be the mechanism for the more common
of the Apert syndrome and achondroplasia mutations,
each of which occurs within a CpG dinucleotide.
In this study, however, none of the 11 mutations oc-
curred within the context of a CpG dinucleotide.
Among the mutations that occurred in the informa-
tive patients (table 2), the C278F, C342R, and C342Y
mutations occurred most frequently, which reflects the
overall occurrence of each mutation in Crouzon syn-
drome and Pfeiffer syndrome (Passos-Bueno et al.
1999). The frequencies of these mutations would most
certainly be less than those of the mutations causing
Apert syndrome and achondroplasia. This is more ev-
idence to suggest that perhaps another mechanism is
responsible for the advanced paternal-age effect. It is
intriguing that all of the mutations previously men-
tioned for achondroplasia, Apert syndrome, Crouzon
syndrome, and Pfeiffer syndrome are point mutations,
occur in FGFR genes, are paternal in origin, and have
an advanced paternal-age effect. One such mechanism
could be the effect of cis sequences on mutations. We
examined the haplotype background on which the mu-
tation occurred. No significant difference between back-
grounds was found.
Oldridge et al. (1997) proposed that “the high ap-
parent rates for several FGFR mutations could arise by
a selective advantage conferred to the mutated male
germ cell.” With any mutation, there is a bias in de-
tecting those mutations that cause a phenotype. Inherent
in this is the fact that the cell with the mutation must
be able to survive, and, in this case, maybe those mu-
tations that are occurring at an increasing rate in the
sperm of older men somehow confer a selective advan-
tage over other sperm without the mutations. We an-
ticipate that future studies will clarify the underlying
mechanism(s) responsible for the paternal origin of mu-
tations as well as for the paternal-age effect.
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